Asuragen Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 99

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $321M

Asuragen General Information

Description

Manufacturer of molecular diagnostic products designed to optimize patient management in oncology and genetic diseases. The company offers a wide range of kits and assays for genetic sequencing as well as cancer monitoring, enabling the medical community to enhance treatment outcomes through accurate data.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 2150 Woodward Street
  • Suite 100
  • Austin, TX 78744
  • United States
+1 (877)
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Discovery Tools (Healthcare)
Parent Company
Corporate Office
  • 2150 Woodward Street
  • Suite 100
  • Austin, TX 78744
  • United States
+1 (877)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Asuragen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 06-Apr-2021 $321M Completed Generating Revenue
6. Debt - PPP 27-Apr-2020 Completed Generating Revenue
5. Later Stage VC (Series C) 20-Mar-2013 Completed Generating Revenue
4. Grant 30-Mar-2012 Completed Generating Revenue
3. Later Stage VC (Series C) 11-Aug-2011 Completed Generating Revenue
2. Grant 08-Oct-2008 $3.8M $18.5M Completed Startup
1. Early Stage VC (Series B) 10-Dec-2007 $18.5M $18.5M Completed Startup
To view Asuragen’s complete valuation and funding history, request access »

Asuragen Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C
Series B
Series A 48,895,000 $0.001000 $1 $1 1x $1 56.29%
To view Asuragen’s complete cap table history, request access »

Asuragen Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of molecular diagnostic products designed to optimize patient management in oncology and genetic diseases.
Diagnostic Equipment
Austin, TX
99 As of 2026

Boston, MA
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Asuragen Competitors (13)

One of Asuragen’s 13 competitors is Foundation Medicine, a Formerly VC-backed company based in Boston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Foundation Medicine Formerly VC-backed Boston, MA
Illumina Formerly VC-backed San Diego, CA
Bio-Techne Corporation Minneapolis, MN
CIS Bio International Formerly PE-Backed Saclay, France
Admera Health Venture Capital-Backed South Plainfield, NJ
You’re viewing 5 of 13 competitors. Get the full list »

Asuragen Patents

Asuragen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210189384-A1 Methods and compositions for amplicon concatenation Inactive 26-Nov-2019
US-11236384-B2 Methods of rna amplification Active 19-Jan-2017
US-12139755-B2 Methods of rna amplification Active 19-Jan-2017
US-20200140923-A1 Methods of rna amplification Active 19-Jan-2017
US-20220177949-A1 Methods of rna amplification Active 19-Jan-2017 C12Q1/686
To view Asuragen’s complete patent history, request access »

Asuragen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Asuragen Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cancer Prevention and Research Institute of Texas Government
Growth Capital Fund Venture Capital Minority
MSD Global Health Innovation Fund Corporate Venture Capital Minority
PTV Healthcare Capital Venture Capital Minority
Southwest Middle Market M&A Merchant Banking Firm Minority
You’re viewing 5 of 7 investors. Get the full list »

Asuragen Investments (2)

Asuragen’s most recent deal was a Early Stage VC with Mirna Therapeutics for . The deal was made on 01-Jan-2009.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Mirna Therapeutics 01-Jan-2009 Early Stage VC Biotechnology
Mirna Therapeutics 04-Apr-2008 Seed Round Biotechnology
To view Asuragen’s complete investments history, request access »

Asuragen FAQs

  • When was Asuragen founded?

    Asuragen was founded in 2005.

  • Where is Asuragen headquartered?

    Asuragen is headquartered in Austin, TX.

  • What is the size of Asuragen?

    Asuragen has 99 total employees.

  • What industry is Asuragen in?

    Asuragen’s primary industry is Diagnostic Equipment.

  • Is Asuragen a private or public company?

    Asuragen is a Private company.

  • What is the current valuation of Asuragen?

    The current valuation of Asuragen is .

  • What is Asuragen’s current revenue?

    The current revenue for Asuragen is .

  • How much funding has Asuragen raised over time?

    Asuragen has raised $31M.

  • Who are Asuragen’s investors?

    Cancer Prevention and Research Institute of Texas, Growth Capital Fund, MSD Global Health Innovation Fund, PTV Healthcare Capital, and Southwest Middle Market M&A are 5 of 7 investors who have invested in Asuragen.

  • Who are Asuragen’s competitors?

    Foundation Medicine, Illumina, Bio-Techne, CIS Bio International, and Admera Health are some of the 13 competitors of Asuragen.

  • When was Asuragen acquired?

    Asuragen was acquired on 06-Apr-2021.

  • Who acquired Asuragen?

    Asuragen was acquired by Bio-Techne.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process